Exploring Neuropsychiatric Symptom in Post-therapy Thyroid Disorder Patients: Anxiety Level Assessment

Authors

  • Afroza Naznin SMO, Institute of Nuclear Medicine and Allied Sciences (INMAS), Mitford
  • Farida Yasmin SMO, Institute of Nuclear Medicine and Allied Sciences (INMAS), Mitford
  • Samira Sharmin PMO, INMAS, Mitford
  • Hosne Ara Rahman Director & CMO, INMAS, Mitford

DOI:

https://doi.org/10.3329/bjnm.v26i2.71467

Keywords:

Neuropsychiatric symptom, Hamilton Anxiety Rating Scale, thyroid disorder, anxiety

Abstract

Thyroid disorders often present with an array of cognitive impairment symptoms, including dysphoria, depression, anxiety, psychosis, and apathy. While most of these problems do not impose any severe physical risk, they nonetheless significantly reduce quality of life and wellbeing. Moreover, some symptoms, like anxiety, tend to persist even after the restoration of biochemical euthyroid status. Hence, this study was designed to evaluate the level of anxiety with a structured questionnaire (the Hamilton Anxiety Rating Scale) in post-therapy thyroid carcinoma as well as hyperthyroidism patients. Study findings implied that most of the post-therapy patients experience only a low level of residual anxiety symptoms, which are unrelated to their initial diagnosis and biochemical thyroid status.

Bangladesh J. Nuclear Med. 26(2): 110-114, 2023

Downloads

Download data is not yet available.
Abstract
34
PDF
58

Downloads

Published

2024-06-23

How to Cite

Naznin, A., Yasmin, F., Sharmin, S., & Rahman, H. A. (2024). Exploring Neuropsychiatric Symptom in Post-therapy Thyroid Disorder Patients: Anxiety Level Assessment. Bangladesh Journal of Nuclear Medicine, 26(2), 110–114. https://doi.org/10.3329/bjnm.v26i2.71467

Issue

Section

Original Articles